Merck, Hanmi to develop Efinopegdutide, an Investigational Therapy for NASH

Korea |  News | 0 Comment | 10 Aug, 2020

Merck, and Hanmi Pharmaceutical (Korea-based pharmaceutical company) on 4 August 2020 announced that the companies hav...Read more

Samsung Biologics launches S-CHOice cell line expression technology

Korea |  News | 0 Comment | 06 Aug, 2020

South Korean firm Samsung Biologics held an online ceremony to announce the launch of its proprietary cell line technolo...Read more

Macrogen obtains CE-IVD mark for COVID-19 test kit

Korea |  News | 0 Comment | 04 Aug, 2020

Korean biotech company Macrogen has recently announced that it has obtained the CE marking for Europe's I...Read more

PharmAbcine, SLBio to evaluate combination therapy to treat NSCLC

Korea |  News | 0 Comment | 05 Aug, 2020

South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...Read more

GC Pharma Files IND for Hyperimmune Globulin-based Therapy for COVID-19

Korea |  News | 0 Comment | 03 Aug, 2020

Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...Read more

Seegene receives expanded EUA for COVID-19 diagnostic assay

Korea |  News | 0 Comment | 31 Jul, 2020

South Korean firm Seegene, Inc. has announced that U.S. Food and Drug Administration (FDA) has further expanded the emer...Read more

Samsung Biologics expands drug product manufacturing facility in Incheon

Korea |  News | 0 Comment | 24 Jul, 2020

South Korean firm Samsung Biologics has announced a plan to expand its Drug Product (DP) capability in line with increas...Read more

Celltrion launches human trial of potential COVID-19 Ab treatment

Korea |  News | 0 Comment | 23 Jul, 2020

South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...Read more

Samsung Biologics announces strong results for Q2 FY21

Korea |  News | 0 Comment | 22 Jul, 2020

South Korea based Samsung Biologics recently announced strong financial results for its fiscal 2020 second quarter endin...Read more

CGBIO to seize Korean premium filler market

Korea |  News | 0 Comment | 22 Jul, 2020

CGBIO, first medical healthcare company to successfully develop an aesthetic premium filler 'Giselleligne' using the R2 ...Read more

Korea's VUNO showcases AI-powered radiology solutions at ECR 2020

Korea |  News | 0 Comment | 15 Jul, 2020

VUNO Inc., South Korean artificial intelligence (AI) developer is showcasing its solutions at the European Con...Read more

BaseLaunch expands pharma-biotech venture funding to APAC

Korea |  News | 0 Comment | 17 Jul, 2020

Bridge Biotherapeutics Inc., a clinical-stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunc...Read more

Samsung Biologics, ImmuneOncia enter manufacturing development agreement

Korea |  News | 0 Comment | 16 Jul, 2020

South Korea based companies Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to dev...Read more

AVATAMED Partners CBmed in Europe on Precision Cancer Project

Korea |  News | 0 Comment | 13 Jul, 2020

AVATAMED and CBmed, together with AIMEDBIO and Shimadzu Corporation, are collaborating in a Precision Cancer Project, le...Read more

Samsung Biologics signs additional agreement with STCube

Korea |  News | 0 Comment | 14 Jul, 2020

South Korea based Samsung Biologics has further expanded its partnership with STCube through an additional development a...Read more

WellsCare targets smart health device market

Korea |  News | 0 Comment | 09 Jul, 2020

South Korean startup WellsCare, a member company of the Born2Global Centre (B2G), will be expanding its presence in the&...Read more

Daewoong Pharma expands influence across Asia

Korea |  News | 0 Comment | 08 Jul, 2020

Korea's Daewoong Pharmaceutical’s original botulinum toxin product Nabota is stepping up to expand its influence a...Read more

Oculight plans expansion in the US market

Korea |  News | 0 Comment | 07 Jul, 2020

Oculight announced the launching of OCU L&C, a fully-owned U.S. subsidiary of Oculight, in 2019 as the platform for ...Read more